Skip to main content
. 2013 Oct 29;109(10):2579–2586. doi: 10.1038/bjc.2013.619

Figure 4.

Figure 4

Expression of AR in tumour before EZN-4176 (top) treatment and 24 h after dosing on cycle 1 day 16 (bottom). No significant AR depletion was observed. AR antibody targeting the amino terminus (A) and carboxy terminus domain (B) of AR.